• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Tempus, Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas

by Jasmine Pennic 06/11/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tempus, Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas

Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale announced today that it was selected by Leidos Biomedical Research Inc. (Leidos Biomed) to abstract and structure follow-up clinical data for The Cancer Genome Atlas (TCGA) Project for submission to the National Cancer Institute’s Genomic Data Commons (GDC).

The Cancer Genome Atlas (TCGA) Project Background

There are 230 distinct investigators that contributed samples to TCGA, with 10,000 cases represented by 100 contributing institutions. While the genomic data from TCGA has been transformative for research, continuing to enrich the dataset can increase its usefulness for researchers and clinicians.  To make the TCGA resource even more useful, Tempus is working with Leidos Biomed on behalf of the NCI to obtain up-to-date medical records for clinical data abstraction.

Collaboration Details

As part of this collaboration, Tempus will reach out to these contributors and/or their institutions to obtain up-to-date medical records for clinical data abstraction. Then, using its Tempus O platform, which employs a sophisticated combination of technologies, such as optical character recognition and natural language processing algorithms, along with qualified healthcare professionals, Tempus will clean and structure the collected data, which will then get paired with the corresponding molecular data.  This ‘upgraded’ TCGA dataset will then be made publicly available for researchers around the world, as the current TCGA data is today.

“A current limitation of the TCGA’s genomic dataset is the modest amount of follow-up clinical data that is available,” said Kevin White, President of Tempus. “We are pleased to support the NCI and the many medical centers whose investigators have contributed to TCGA, and we are eager to integrate these important datasets in pursuit of research and improved patient care.”

“We chose Tempus for this task because of their track record of successful partnerships with NCI designated cancer centers and their advanced technology for abstracting the required clinical data for this project,” said Nancy Roche, Director, Leidos Biomed Biospecimen Research Group.

The TCGA genomic dataset is a landmark cancer genomics program that has molecularly characterized over 20,000 primary cancer and matched normal samples spanning 33 cancer types. This joint effort between the National Cancer Institute and the National Human Genome Research Institute began in 2006.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: algorithms, cancer, Cancer Genomics, dataset, genomic data, genomics, Leidos, medical records, Patient Care, Precision Medicine, Precision Oncology, Roche, Tempus

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

 How Top Health Plans Use AI to Save Money and Work Smarter How Top Health Plans Use AI to Save Money and Work Smarter

 How to Build Hybrid Care Models Around Remote Patient Monitoring How to Build Hybrid Care Models Around Remote Patient Monitoring

Trending

Nearly Half Of Consumers Report Their Healing has Been Directly Impacted by Difficulty Paying Medical Bills

Consumers Cite Healthcare Affordability as Biggest Concern to Paying Medical Bills

Mayo Clinic, GE HealthCare, Partner on Medical Imaging and Theranostics Innovation

Roundups: 16 Recent Strategic Digital Health Partnerships

How Telehealth Can Combat Clinician Burnout

How Telehealth Can Combat Clinician Burnout

Q/A: DocStation CEO Shares How AI Will Help Pharmacies Use the DIR Fee Changes to Their Advantage

Q/A: DocStation CEO Shares How AI Will Help Pharmacies Use the DIR Fee Changes to Their Advantage

Debunking Myths About Virtual Care to Drive Health Equity

Debunking 3 Myths About Virtual Care to Drive Health Equity

Provider AI Strategy Moves From The IT Dept. To The C-Suite

Notable Launches ChatGPT-Like Assistant for Patients

Notable Launches ChatGPT-Like Assistant for Patients

Intermountain to Replace Cerner with Epic Enterprise EHR by 2025

Intermountain to Replace Cerner with Epic Enterprise EHR by 2025

M&A: PE Firm Acquires NextGen Healthcare EHR for $1.8B

M&A: NextGen Healthcare EHR Acquired by PE Firm for $1.8B

UPMC to Replace Oracle Cerner with Epic Enterprise EHR by 2026

UPMC to Replace Oracle Cerner with Epic Enterprise EHR by 2026

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |